tofisopam has been researched along with Peptic Ulcer in 1 studies
tofisopam: structure; dextofisopam is the R-enantiomer of tofisopam & antidiarrheal
Peptic Ulcer: Ulcer that occurs in the regions of the GASTROINTESTINAL TRACT which come into contact with GASTRIC JUICE containing PEPSIN and GASTRIC ACID. It occurs when there are defects in the MUCOSA barrier. The common forms of peptic ulcers are associated with HELICOBACTER PYLORI and the consumption of nonsteroidal anti-inflammatory drugs (NSAIDS).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vakhrushev, IaM | 1 |
| Belova, EV | 1 |
| Efremova, LI | 1 |
1 trial available for tofisopam and Peptic Ulcer
| Article | Year |
|---|---|
[Use of grandaxine in the treatment of patients with erosive-ulcerative stomach and gastroduodenal lesions].
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antidepressive Agents; Autonomic Nervous System; Benzodi | 2004 |